214 related articles for article (PubMed ID: 26047605)
1. MiR-503 inhibited cell proliferation of human breast cancer cells by suppressing CCND1 expression.
Long J; Ou C; Xia H; Zhu Y; Liu D
Tumour Biol; 2015 Nov; 36(11):8697-702. PubMed ID: 26047605
[TBL] [Abstract][Full Text] [Related]
2. miR-211 suppresses epithelial ovarian cancer proliferation and cell-cycle progression by targeting Cyclin D1 and CDK6.
Xia B; Yang S; Liu T; Lou G
Mol Cancer; 2015 Mar; 14():57. PubMed ID: 25889927
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of miR-660-5p expression suppresses tumor development and metastasis in human breast cancer.
Shen Y; Ye YF; Ruan LW; Bao L; Wu MW; Zhou Y
Genet Mol Res; 2017 Feb; 16(1):. PubMed ID: 28252173
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-374b inhibits breast cancer progression through regulating CCND1 and TGFA genes.
Liu Y; Zhang A; Bao PP; Lin L; Wang Y; Wu H; Shu XO; Liu A; Cai Q
Carcinogenesis; 2021 Apr; 42(4):528-536. PubMed ID: 33480984
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of microRNA-16 declines cellular growth, proliferation and induces apoptosis in human breast cancer cells.
Mobarra N; Shafiee A; Rad SM; Tasharrofi N; Soufi-Zomorod M; Hafizi M; Movahed M; Kouhkan F; Soleimani M
In Vitro Cell Dev Biol Anim; 2015 Jun; 51(6):604-11. PubMed ID: 25672252
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-892b influences proliferation, migration and invasion of bladder cancer cells by mediating the p19ARF/cyclin D1/CDK6 and Sp-1/MMP-9 pathways.
Shin SS; Park SS; Hwang B; Moon B; Kim WT; Kim WJ; Moon SK
Oncol Rep; 2016 Oct; 36(4):2313-20. PubMed ID: 27573859
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-503 suppresses proliferation and cell-cycle progression of endometrioid endometrial cancer by negatively regulating cyclin D1.
Xu YY; Wu HJ; Ma HD; Xu LP; Huo Y; Yin LR
FEBS J; 2013 Aug; 280(16):3768-79. PubMed ID: 23731275
[TBL] [Abstract][Full Text] [Related]
8. MiR-124 inhibits cell proliferation in breast cancer through downregulation of CDK4.
Feng T; Xu D; Tu C; Li W; Ning Y; Ding J; Wang S; Yuan L; Xu N; Qian K; Wang Y; Qi C
Tumour Biol; 2015 Aug; 36(8):5987-97. PubMed ID: 25731732
[TBL] [Abstract][Full Text] [Related]
9. MiR-32 contributed to cell proliferation of human breast cancer cells by suppressing of PHLPP2 expression.
Xia H; Long J; Zhang R; Yang X; Ma Z
Biomed Pharmacother; 2015 Oct; 75():105-10. PubMed ID: 26276160
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-383 inhibits anchorage-independent growth and induces cell cycle arrest of glioma cells by targeting CCND1.
Xu Z; Zeng X; Tian D; Xu H; Cai Q; Wang J; Chen Q
Biochem Biophys Res Commun; 2014 Oct; 453(4):833-8. PubMed ID: 25450356
[TBL] [Abstract][Full Text] [Related]
11. MiR-492 contributes to cell proliferation and cell cycle of human breast cancer cells by suppressing SOX7 expression.
Shen F; Cai WS; Feng Z; Li JL; Chen JW; Cao J; Xu B
Tumour Biol; 2015 Mar; 36(3):1913-21. PubMed ID: 25407488
[TBL] [Abstract][Full Text] [Related]
12. miR-30a suppresses breast cancer cell proliferation and migration by targeting Eya2.
Fu J; Xu X; Kang L; Zhou L; Wang S; Lu J; Cheng L; Fan Z; Yuan B; Tian P; Zheng X; Yu C; Ye Q; Lv Z
Biochem Biophys Res Commun; 2014 Mar; 445(2):314-9. PubMed ID: 24508260
[TBL] [Abstract][Full Text] [Related]
13. miR-381 inhibited breast cancer cells proliferation, epithelial-to-mesenchymal transition and metastasis by targeting CXCR4.
Xue Y; Xu W; Zhao W; Wang W; Zhang D; Wu P
Biomed Pharmacother; 2017 Feb; 86():426-433. PubMed ID: 28012397
[TBL] [Abstract][Full Text] [Related]
14. Tumor-suppressing effects of miR451 in human osteosarcoma.
Xu H; Mei Q; Shi L; Lu J; Zhao J; Fu Q
Cell Biochem Biophys; 2014 May; 69(1):163-8. PubMed ID: 24218283
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of miR-34a contributes to the proliferation and migration of laryngeal carcinoma cells by targeting cyclin D1.
Ye J; Li L; Feng P; Wan J; Li J
Oncol Rep; 2016 Jul; 36(1):390-8. PubMed ID: 27220728
[TBL] [Abstract][Full Text] [Related]
16. microRNA-335 inhibits proliferation, cell-cycle progression, colony formation, and invasion via targeting PAX6 in breast cancer cells.
Meng Y; Zou Q; Liu T; Cai X; Huang Y; Pan J
Mol Med Rep; 2015 Jan; 11(1):379-85. PubMed ID: 25323813
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-1254 exerts oncogenic effects by directly targeting RASSF9 in human breast cancer.
Li B; Chen P; Wang J; Wang L; Ren M; Zhang R; He J
Int J Oncol; 2018 Nov; 53(5):2145-2156. PubMed ID: 30132526
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of miR-34a Effect on CCND1 mRNA Level and Sensitization of Breast Cancer Cell Lines to Paclitaxel.
Irani S; Paknejad M; Soleimani M; Azam S
Iran Biomed J; 2020 Nov; 24(6):361-9. PubMed ID: 32660221
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-490-3p inhibits proliferation of A549 lung cancer cells by targeting CCND1.
Gu H; Yang T; Fu S; Chen X; Guo L; Ni Y
Biochem Biophys Res Commun; 2014 Jan; 444(1):104-8. PubMed ID: 24440705
[TBL] [Abstract][Full Text] [Related]
20. Genetic analysis and preliminary function study of miR-423 in breast cancer.
Zhao H; Gao A; Zhang Z; Tian R; Luo A; Li M; Zhao D; Fu L; Fu L; Dong JT; Zhu Z
Tumour Biol; 2015 Jun; 36(6):4763-71. PubMed ID: 25663458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]